ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Scienture Holdings Inc

Scienture Holdings Inc (SCNX)

0.9445
-0.0655
( -6.49% )
Updated: 12:58:58

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.9445
Bid
0.94
Ask
0.96
Volume
57,443
0.94 Day's Range 1.0072
0.69 52 Week Range 9.55
Market Cap
Previous Close
1.01
Open
0.94
Last Trade
75
@
0.9445
Last Trade Time
12:58:58
Financial Volume
US$ 55,401
VWAP
0.964457
Average Volume (3m)
2,980,026
Shares Outstanding
12,515,019
Dividend Yield
-
PE Ratio
10.48
Earnings Per Share (EPS)
0.72
Revenue
137k
Net Profit
9.07M

About Scienture Holdings Inc

Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engage... Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide. Show more

Sector
Drugs And Proprietary-whsl
Industry
Drugs And Proprietary-whsl
Headquarters
Dover, Delaware, USA
Founded
-
Scienture Holdings Inc is listed in the Drugs And Proprietary-whsl sector of the NASDAQ with ticker SCNX. The last closing price for Scienture was US$1.01. Over the last year, Scienture shares have traded in a share price range of US$ 0.69 to US$ 9.55.

Scienture currently has 12,515,019 shares outstanding. The market capitalization of Scienture is US$12.64 million. Scienture has a price to earnings ratio (PE ratio) of 10.48.

SCNX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.105312.54766444230.83921.040.803456745870.93207408CS
4-0.4855-33.9510489511.431.480.691847980.98978588CS
12-2.7055-74.12328767123.653.70.6929800261.97482589CS
26-7.4979-88.81242300778.44249.550.6914230841.99714963CS
52-7.0455-88.17897371717.999.550.6911750742.00626837CS
156-7.0455-88.17897371717.999.550.6911750742.00626837CS
260-7.0455-88.17897371717.999.550.6911750742.00626837CS

SCNX - Frequently Asked Questions (FAQ)

What is the current Scienture share price?
The current share price of Scienture is US$ 0.9445
How many Scienture shares are in issue?
Scienture has 12,515,019 shares in issue
What is the market cap of Scienture?
The market capitalisation of Scienture is USD 12.64M
What is the 1 year trading range for Scienture share price?
Scienture has traded in the range of US$ 0.69 to US$ 9.55 during the past year
What is the PE ratio of Scienture?
The price to earnings ratio of Scienture is 10.48
What is the cash to sales ratio of Scienture?
The cash to sales ratio of Scienture is 696.33
What is the reporting currency for Scienture?
Scienture reports financial results in USD
What is the latest annual turnover for Scienture?
The latest annual turnover of Scienture is USD 137k
What is the latest annual profit for Scienture?
The latest annual profit of Scienture is USD 9.07M
What is the registered address of Scienture?
The registered address for Scienture is 850 NEW BURTON ROAD, SUITE 201, DOVER, DELAWARE, 19904
What is the Scienture website address?
The website address for Scienture is www.trxadehealth.com
Which industry sector does Scienture operate in?
Scienture operates in the DRUGS AND PROPRIETARY-WHSL sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WWWW International Inc
US$ 0.869
(110.16%)
502.7M
DMNDamon Inc
US$ 0.0075
(97.37%)
2.92B
HIMZDefiance Daily Target 2X Long HIMS ETF
US$ 18.6374
(53.02%)
3.31M
ULYUrgent ly Inc
US$ 11.46
(52.80%)
1.67M
LGMKLogicMark Inc
US$ 0.0196
(51.94%)
2.59B
PTPIPetros Pharmaceuticals Inc
US$ 0.0134
(-76.86%)
289.68M
IXHLIncannex Healthcare Ltd
US$ 0.1471
(-75.89%)
15.22M
IOTRiOThree Ltd
US$ 0.475
(-47.80%)
2.38M
ZYBTZhengye Biotechnology Holding Ltd
US$ 8.7745
(-37.99%)
984.29k
NEONeoGenomics Inc
US$ 6.70
(-32.80%)
6.61M
DMNDamon Inc
US$ 0.0075
(97.37%)
2.92B
LGMKLogicMark Inc
US$ 0.0198
(53.49%)
2.59B
WWWW International Inc
US$ 0.8689
(110.13%)
502.75M
PTPIPetros Pharmaceuticals Inc
US$ 0.0134
(-76.86%)
289.82M
GNLNGreenlane Holdings Inc
US$ 0.0119
(-0.83%)
271.3M

Discussion

View Full Feed
doc2016 doc2016 1 minute ago
8 now has 8x8 pay for google and apple pay.. could this be rcs ploinks/puddle ip?
IONQ
m0n m0n 1 minute ago
Deficits increase every year proven by the fins posted on OTCMarkets signed by the Stooge in Charge LoL
No One is Fooled 



IFUS
Carjockey2 Carjockey2 1 minute ago
So much interest here..how come??
TWOH
Trooperstocks Trooperstocks 1 minute ago
$BEAT interesting NEWS Out Today as HeartBeam, Inc Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology - Milestone results formed the basis of HeartBeam’s 12-lead ECG synthesis software application submitted to FDA in January 2025 https://bu
BEAT
Trooperstocks Trooperstocks 2 minutes ago
$BEAT interesting NEWS Out Today as HeartBeam, Inc Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology - Milestone results formed the basis of HeartBeam’s 12-lead ECG synthesis software application submitted to FDA in January 2025 https://bu
BEAT
stocktowatch stocktowatch 2 minutes ago
$ALLR Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025
TARPON SPRINGS, Fla., April 25, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated
ALLR
glenn1919 glenn1919 2 minutes ago
IFRX........LNZA........ABAT..............................https://www.stockscores.com/charts/charts/?ticker=ABAT
ABAT IFRX LNZA
81vette 81vette 2 minutes ago
BOIL(natural gas futures ETF) every year
I buy now(early spring low)sell in early -mid summer,(sometimes only a month or 2 later I am up 100%) BOIL is best played in a disaster(1 or 2 big nation wide ice/snow storms every winter work best,hurricanes are ok,world events,war,pipeline events,oil
privatee privatee 2 minutes ago
Looks like they are just swapping shares..
VMST
IRON_CROSS IRON_CROSS 2 minutes ago
Good call for now it seems...
LGMK
Large Green Large Green 2 minutes ago
Old Email - Relevant Concerning Servicing Platforms - COOP Buying Former WaMu PLATFORMs?



COOP Buying Former WaMu PLATFORMs**OCN Next**Look Who Owns LARGE STYLE Positions in COOP/OCN -Leon Cooperman-Read on

So of the five servicers that were mentioned in
SLS
NebraskaOTC NebraskaOTC 3 minutes ago
Calling out scams and scamm-ERs is the fun part.
Right FAM?!?!?!? :-D
VGTL
BadCuda BadCuda 3 minutes ago
IRWD about to boosh .985 now coiling up nicely 
IRWD
resx18 resx18 3 minutes ago
South America's CBD market projected to surpass $4.9 billion by 2028
CBDL
m0n m0n 3 minutes ago
Livestock feeding since 2013 LoL and here we are, deficts exceed $2.2 milly and the same oL pump/paid awareness campaign continues as deficits increase.
No One is Fooled 
IFUS
Spuds McKenz66 Spuds McKenz66 3 minutes ago
got some more PLUG
PLUG
tnyellowtomcat tnyellowtomcat 3 minutes ago
Dots,

A 10 cent add on price would REALLY irritate the penny flippers!

Watching this happen & their reaction is the sport of Kings!

VBG - Tomcat
LQMT
BurtMacklinfbi BurtMacklinfbi 3 minutes ago
I see the circus is back in town.
NWBO
Laster Laster 3 minutes ago
Just hit $3.20. I like the slow grind forward. I like the story.
I really think we will hit $5 in the several months.
Just keep the good news. Hopefully the market won’t throw any curveballs.
Enjoy.
NEOV
exwannabe exwannabe 3 minutes ago
I remain with my assessment, which is that at the end of last March, they received a new RFI following the data inspections at the medical trial sites, and that clock-off period is what we are in now.
So LP is in a clock stop.

Why does this not surprise me?
NWBO
TucsonPhil TucsonPhil 3 minutes ago
Are you not realizing the plan? Let the sick people die, so they will be off of the social welfare programs. Take away Narcan, so the druggies die. Only the strong, healthy citizens should survive, thereby making the gene pool stronger. Sounds a lot like 80 odd years ago on another continent.
TSLA
WolfofMia WolfofMia 3 minutes ago
Making Dr.M look like a pretty smart guy once again thank you.

EMA vs FDA..... Boom!
AVXL
Lone Clone Lone Clone 4 minutes ago
GR Silver Mining Announces Temporary Plomosas Silver Project Field Work Pause

https://www.newswire.ca/news-releases/gr-silver-mining-announces-temporary-plomosas-silver-project-field-work-pause-802139472.html

News provided by GR Silver Mining Ltd. Apr 29, 2025, 07:30 E
FrostyEmpire44 FrostyEmpire44 4 minutes ago
basically...some good news

https://www.cnbc.com/2025/04/29/trump-india-trade-deal-bessent-south-korea-japan.html

https://www.cnbc.com/2025/04/29/commerce-secretary-lutnick-trade-deal-unnamed-country-approval.html

Not GSE news but it is helping overall mar
FNMA
resx18 resx18 4 minutes ago
New manufacturing deal positions CBDL to tap into the $4.9 billion Latin American CBD market, unlocking major revenue growth and accelerating international expansion.
CBDL

Your Recent History

Delayed Upgrade Clock